ConductScience.org, home

Paper36932180

Psychedelics: preclinical insights provide directions for future research.

Gumpper RH and 1 other. Neuropsychopharmacology, 2024. Cited by 13 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Psychedelics: preclinical insights provide directions for future research. Papers, record 36932180. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36932180

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Psychedelics: preclinical insights provide directions for future research.
PubMed
Journal
Neuropsychopharmacology
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
2.63, provisional
iCite
Revised in PubMed
2026-05-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gumpper RHRyan H
2Roth BLBryan Lhttps://orcid.org/0000-0002-0561-6520

Source PubMed

Topics1

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HallucinogensMajor topic

Source PubMed

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126,841,800Psychedelics.Pharmacol Rev2016https://conductscience.org/library/papers/26841800PubMed
235,301,459The promises and perils of psychedelic pharmacology for psychiatry.Nat Rev Drug Discov2022https://conductscience.org/library/papers/35301459PubMed
327,909,165Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.J Psychopharmacol2016https://conductscience.org/library/papers/27909165PubMed
427,909,164Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.J Psychopharmacol2016https://conductscience.org/library/papers/27909164PubMed
533,852,780Trial of Psilocybin versus Escitalopram for Depression.N Engl J Med2021https://conductscience.org/library/papers/33852780PubMed
636,322,843Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.N Engl J Med2022https://conductscience.org/library/papers/36322843PubMed
82,943LSD as an agonist at mesolimbic dopamine receptors.Psychopharmacologia1975https://conductscience.org/library/papers/2943PubMed
93,336,031[125I]-1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors.J Med Chem1988https://conductscience.org/library/papers/3336031PubMed
103,437,942Binding to the serotonin 5-HT2 receptor by the enantiomers of 125I-DOI.Neuropharmacology1987https://conductscience.org/library/papers/3437942PubMed
1125,895,059PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome.Nat Struct Mol Biol2015https://conductscience.org/library/papers/25895059PubMed
125,567,294Quipazine, a new type of antidepressant agent.Psychopharmacologia1971https://conductscience.org/library/papers/5567294PubMed
136,513,725Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.Life Sci1984https://conductscience.org/library/papers/6513725PubMed
1431,917,152Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.Neuropharmacology2020https://conductscience.org/library/papers/31917152PubMed
152,843,634Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.J Pharmacol Exp Ther1988https://conductscience.org/library/papers/2843634PubMed
167,099,138[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.Mol Pharmacol1982https://conductscience.org/library/papers/7099138PubMed
179,875,725Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.Neuroreport1998https://conductscience.org/library/papers/9875725PubMed
1822,578,254Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.Biol Psychiatry2012https://conductscience.org/library/papers/22578254PubMed
1932,946,782Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor.Cell2020https://conductscience.org/library/papers/32946782PubMed
2036,171,289Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity.Nature2022https://conductscience.org/library/papers/36171289PubMed
2117,270,739Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.Neuron2007https://conductscience.org/library/papers/17270739PubMed

See all 64 references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42,828,395The Emergence of Isotryptamine Analogs as Novel Serotonergic Agents with Psychotherapeutic Potential.ACS Pharmacol Transl Sci2026https://conductscience.org/library/papers/42828395PubMed
40,534,669The Selective Serotonin 5‑HT2A Receptor Agonist (S)‑3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40534669PubMed
39,900,337Molecular Glues: A New Approach to Modulating GPCR Signaling Bias.Biochemistry2025https://conductscience.org/library/papers/39900337PubMed
39,833,376Effects of psychedelics on opioid use disorder: a scoping review of preclinical studies.Cell Mol Life Sci2025https://conductscience.org/library/papers/39833376PubMed
39,094,057Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money.Annu Rev Psychol2025https://conductscience.org/library/papers/39094057PubMed
38,898,9561-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents - A Review.ACS Pharmacol Transl Sci2024https://conductscience.org/library/papers/38898956PubMed
38,743,110Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.Psychopharmacology (Berl)2025https://conductscience.org/library/papers/38743110PubMed
38,340,182Effects of congeners of amphetamine on the human heart.Naunyn Schmiedebergs Arch Pharmacol2024https://conductscience.org/library/papers/38340182PubMed
38,093,842α-Ethyltryptamine: A Ratiocinatory Review of a Forgotten Antidepressant.ACS Pharmacol Transl Sci2023https://conductscience.org/library/papers/38093842PubMed
38,011,560Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/38011560PubMed
37,488,282Therapeutic mechanisms of psychedelics and entactogens.Neuropsychopharmacology2024https://conductscience.org/library/papers/37488282PubMed
37,067,459G protein-coupled receptors as targets for transformative neuropsychiatric therapeutics.Am J Physiol Cell Physiol2023https://conductscience.org/library/papers/37067459PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36932180

GET https://conductscience.org/api/papers/v1/36932180/references?page=2